Clinical Transplants 2016 Individual Chapter Downloads



Product Compare (0)


Intestinal Bioengineering

Intestinal Bioengineering

Intestinal Bioengineering.James C.Y. DunnClinical Transplants 2016, Chapter 1AbstractThis review sum..

$5.00

Long-term Outcomes in Intestinal Rehabilitation in Children

Long-term Outcomes in Intestinal Rehabilitation in Children

Long-term Outcomes in Intestinal Rehabilitation in Children.Danielle Wendel and Simon P. HorslenClin..

$5.00

Donor-Specific HLA Antibodies: A Review of Data Published in 2016

Donor-Specific HLA Antibodies: A Review of Data Published in 2016

Donor-Specific HLA Antibodies: A Review of Data Published in 2016.Adam Idica and Matthew J. EverlyCl..

$5.00

Cytokines as Biomarkers for Renal Transplant Recipients: What is New?

Cytokines as Biomarkers for Renal Transplant Recipients: What is New?

Cytokines as Biomarkers for Renal Transplant Recipients: What is New?Satoru Kawakita and Matthew J. ..

$5.00

The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation

The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation

The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation.Kyle Freischlag, Meghan H. ..

$5.00

Non-HLA Antibodies in Clinical Transplantation

Non-HLA Antibodies in Clinical Transplantation

Non-HLA Antibodies in Clinical Transplantation.Chitranon Chan-on and Minnie SarwalClinical Transplan..

$5.00

HLA Epitopes – Are We Ready for Clinical Prime Time? Historic Perspective and Future Needs

HLA Epitopes – Are We Ready for Clinical Prime Time? Historic Perspective and Future Needs

HLA Epitopes - Are We Ready for Clinical Prime Time? Historic Perspective and Future Needs.Reut Hod ..

$5.00

HLA Epitopes and Shared Molecular Eplet Characterization and Their Implication on Transplant Outcome: The Experience of One Center

HLA Epitopes and Shared Molecular Eplet Characterization and Their Implication on Transplant Outcome: The Experience of One Center

HLA Epitopes and Shared Molecular Eplet Characterization and Their Implication on Transplant Outcome..

$5.00

Pre-empting Antibody-Mediated Rejection: A Program of DSA Monitoring and Treatment Can Effectively Prevent Antibody Mediated Rejection

Pre-empting Antibody-Mediated Rejection: A Program of DSA Monitoring and Treatment Can Effectively Prevent Antibody Mediated Rejection

Pre-empting Antibody-Mediated Rejection: A Program of DSA Monitoring and Treatment Can Effectively P..

$5.00

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.Sa..

$5.00

Late Antibody-Mediated Rejection in Kidney Transplant Recipients: Outcomes After Intravenous Immunoglobulin Therapy

Late Antibody-Mediated Rejection in Kidney Transplant Recipients: Outcomes After Intravenous Immunoglobulin Therapy

Late Antibody-Mediated Rejection in Kidney Transplant Recipients: Outcomes After Intravenous Immunog..

$5.00

Outcomes in Simultaneous Liver Kidney Transplants in the Setting of a Positive Crossmatch: A Single Center Experience

Outcomes in Simultaneous Liver Kidney Transplants in the Setting of a Positive Crossmatch: A Single Center Experience

Outcomes in Simultaneous Liver Kidney Transplants in the Setting of a Positive Crossmatch: A Single ..

$5.00

C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients

C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients

C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Ki..

$5.00

Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD)

Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD)

Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes fro..

$5.00

Post-Transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience

Post-Transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience

Post-Transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Exp..

$5.00

From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays

From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays

From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.Guillaume Claisse, Ch..

$5.00

Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients

Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients

Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Rena..

$5.00

Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study

Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study

Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Ret..

$5.00

Showing 1 to 19 of 19 (1 Pages)